ARTICLE | Management Tracks
Plus: Quantum-Si appoints Kummeth independent chair and updates from Alkeus and SAB
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
June 1, 2024 12:47 AM UTC
Verve Therapeutics Inc. (NASDAQ:VERV) promoted Troy Lister to CSO from SVP, research and early development, effective June 21. Lister succeeds CSO Andrew Bellinger, who will become an adviser to the gene editing company. Bellinger paid tribute to Verve and its employees in a LinkedIn post, writing, “at Verve, we created an environment where problem solving happened independently from the bottom up.”
Proteomics company Quantum-Si Inc. (NASDAQ:QSI) appointed Charles Kummeth independent chair. Kummeth was president and CEO of Bio-Techne Corp. (NASDAQ:TECH) for over a decade, until February. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652577/verve-promotes-lister-to-cso